Insulet Corporation (PODD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 180.07 |
| Open | 180.33 |
| Bid | 177.76 x 100 |
| Ask | 178.00 x 100 |
| Day's range | 177.48 - 181.68 |
| 52-week range | 125.82 - 298.95 |
| Volume | |
| Avg. volume | 868,660 |
| Market cap | 12.454B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | 54.05 |
| EPS (TTM) | 3.29 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 232.90 |
Business WireInsulet to Present at the Jefferies Global Healthcare Conference
ACTON, Mass., May 28, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).
ZacksHere's Why Insulet (PODD) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksWhy Insulet (PODD) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
© 2024 Yahoo. All rights reserved.